India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

IJ represented 100Unicorns in the investment round of Alchemyst AI

IJ represents VC Grid and Vcats Group in $3.5 million funding round of Str8bat, a sportstech company

In $10.6 million Series B funding round of Basic Home Loan, IJ acts Legal Counsel to 9Unicorns

Publications

Emerging Biotech Sector: Investment Opportunities and Legal Framework

Green Hydrogen Fund: Fueling Sustainability

Decoding IFSCA (Listing) Regulations, 2024

Newsletters

Consolidated IFSCA (RIB) Regulations, 2021

Advisory on Communication with SEBI Officials

Mediation in Insolvency Proceedings: A Game Changer